Skip Nav Destination
Issues
1 October 2014
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Topics:
albiglutide
,
birth weight
,
diabetes mellitus, type 1
,
gestational weight gain
,
hemoglobin a, glycosylated
Diabetes Care September 2014, Vol.37, 2663-2664. doi:https://doi.org/10.2337/dc14-ti10
Editorial
Joining Forces: A Call for Greater Collaboration to Study New Medicines in Children and Adolescents With Type 2 Diabetes
Janina Karres; Valerie Pratt; Jean-Marc Guettier; Jean Temeck; William V. Tamborlane; David Dunger; Cristina Bejnariu; Carine De Beaufort; Paolo Tomasi
Topics:
child
,
diabetes mellitus, type 2
,
pediatrics
,
adolescent
,
metformin
Diabetes Care September 2014, Vol.37, 2665-2667. doi:https://doi.org/10.2337/dc14-0494
Perspectives in Care
We Can Change the Natural History of Type 2 Diabetes
Topics:
diabetes mellitus, type 2
,
glucose
,
prediabetes
,
hypoglycemia
,
metformin
Diabetes Care September 2014, Vol.37, 2668-2676. doi:https://doi.org/10.2337/dc14-0817
Clinical Care / Education / Nutrition / Psychosocial Research
Higher Gestational Weight Gain Is Associated With Increasing Offspring Birth Weight Independent of Maternal Glycemic Control in Women With Type 1 Diabetes
Anna L. Secher; Clara B. Parellada; Lene Ringholm; Björg Ásbjörnsdóttir; Peter Damm; Elisabeth R. Mathiesen
Topics:
birth weight
,
body mass index procedure
,
diabetes mellitus, type 1
,
gestational weight gain
,
glycemic control
Diabetes Care September 2014, Vol.37, 2677-2684. doi:https://doi.org/10.2337/dc14-0896
Falling Insulin Requirements Are Associated With Adverse Obstetric Outcomes in Women With Preexisting Diabetes
Topics:
insulin
,
pre-eclampsia
,
pregnancy
,
placental dysfunction
Diabetes Care September 2014, Vol.37, 2685-2692. doi:https://doi.org/10.2337/dc14-0506
Cultures of Diabetic Foot Ulcers Without Clinical Signs of Infection Do Not Predict Outcomes
Sue E. Gardner; Ambar Haleem; Ying-Ling Jao; Stephen L. Hillis; John E. Femino; Phinit Phisitkul; Kristopher P. Heilmann; Shannon M. Lehman; Carrie L. Franciscus
Topics:
diabetic foot ulcer
,
infections
,
ulcer
Diabetes Care September 2014, Vol.37, 2693-2701. doi:https://doi.org/10.2337/dc14-0051
Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry
Jenise C. Wong; Nicole C. Foster; David M. Maahs; Dan Raghinaru; Richard M. Bergenstal; Andrew J. Ahmann; Anne L. Peters; Bruce W. Bode; Grazia Aleppo; Irl B. Hirsch; Lora Kleis; H. Peter Chase; Stephanie N. DuBose; Kellee M. Miller; Roy W. Beck; Saleh Adi; for the T1D Exchange Clinic Network
Topics:
continuous glucose monitoring
Diabetes Care September 2014, Vol.37, 2702-2709. doi:https://doi.org/10.2337/dc14-0303
Diabetes-Related Distress, Insulin Dose, and Age Contribute to Insulin-Associated Weight Gain in Patients With Type 2 Diabetes: Results of a Prospective Study
Henry J. Jansen; Gerald M.M. Vervoort; Anton F.J. de Haan; Paetrick M. Netten; Wim J. de Grauw; Cees J. Tack
Topics:
insulin
,
weight gain
,
diabetes mellitus, type 2
Diabetes Care September 2014, Vol.37, 2710-2717. doi:https://doi.org/10.2337/dc13-1205
Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients
Hao Hu; Wenjun Sun; Shuqin Yu; Xiafei Hong; Weiyun Qian; Bingqian Tang; Dong Wang; Ling Yang; Jifang Wang; Caoming Mao; Libin Zhou; Guoyue Yuan
Diabetes Care September 2014, Vol.37, 2718-2722. doi:https://doi.org/10.2337/dc14-0602
Efficacy and Safety of the Once-Weekly GLP-1 Receptor Agonist Albiglutide Versus Sitagliptin in Patients With Type 2 Diabetes and Renal Impairment: A Randomized Phase III Study
Lawrence A. Leiter; Molly C. Carr; Murray Stewart; Angela Jones-Leone; Rhona Scott; Fred Yang; Yehuda Handelsman
Topics:
albiglutide
,
diabetes mellitus, type 2
,
hemoglobin a, glycosylated
,
renal impairment
,
sitagliptin
Diabetes Care September 2014, Vol.37, 2723-2730. doi:https://doi.org/10.2337/dc13-2855
Epidemiology / Health Services Research
Reduced Testing Frequency for Glycated Hemoglobin, HbA1c, Is Associated With Deteriorating Diabetes Control
Owen J. Driskell; David Holland; Jenna L. Waldron; Clare Ford; Jonathan J. Scargill; Adrian Heald; Martin Tran; Fahmy W. Hanna; Peter W. Jones; R. John Pemberton; Anthony A. Fryer
Topics:
hemoglobin a, glycosylated
Diabetes Care September 2014, Vol.37, 2731-2737. doi:https://doi.org/10.2337/dc14-0297
Effects of Weight Loss, Weight Cycling, and Weight Loss Maintenance on Diabetes Incidence and Change in Cardiometabolic Traits in the Diabetes Prevention Program
Linda M. Delahanty; Qing Pan; Kathleen A. Jablonski; Vanita R. Aroda; Karol E. Watson; George A. Bray; Steven E. Kahn; Jose C. Florez; Leigh Perreault; Paul W. Franks; for the Diabetes Prevention Program Research Group
Topics:
weight fluctuation
,
weight reduction
Diabetes Care September 2014, Vol.37, 2738-2745. doi:https://doi.org/10.2337/dc14-0018
Emerging Technologies and Therapeutics
Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
Ronnie Aronson; Peter A. Gottlieb; Jens S. Christiansen; Thomas W. Donner; Emanuele Bosi; Bruce W. Bode; Paolo Pozzilli; the DEFEND Investigator Group
Topics:
adverse event
,
c-peptide
,
diabetes mellitus, type 1
,
hemoglobin a, glycosylated
,
insulin
Diabetes Care September 2014, Vol.37, 2746-2754. doi:https://doi.org/10.2337/dc13-0327
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)
Matthew C. Riddle; Geremia B. Bolli; Monika Ziemen; Isabel Muehlen-Bartmer; Florence Bizet; Philip D. Home; on behalf of the EDITION 1 Study Investigators
Topics:
diabetes mellitus, type 2
,
hypoglycemia
,
insulin
,
insulin glargine
,
mealtimes
Diabetes Care September 2014, Vol.37, 2755-2762. doi:https://doi.org/10.2337/dc14-0991
Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
Michaela Diamant; Michael A. Nauck; Rimma Shaginian; James K. Malone; Simon Cleall; Matthew Reaney; Danielle de Vries; Byron J. Hoogwerf; Leigh MacConell; Bruce H.R. Wolffenbuttel; for the 4B Study Group
Topics:
basal insulin
,
diabetes mellitus, type 2
,
exenatide
,
glucagon-like peptide-1 agonists
,
hemoglobin a, glycosylated
Diabetes Care September 2014, Vol.37, 2763-2773. doi:https://doi.org/10.2337/dc14-0876
Pathophysiology / Complications
Renal Hyperfiltration Is Associated With Glucose-Dependent Changes in Fractional Excretion of Sodium in Patients With Uncomplicated Type 1 Diabetes
Topics:
blood glucose normal
,
diabetes mellitus, type 1
,
fractional sodium excretion
,
glomerular filtration rate
,
glucose
Diabetes Care September 2014, Vol.37, 2774-2781. doi:https://doi.org/10.2337/dc14-0798
Blood Pressure and Pulse Pressure Effects on Renal Outcomes in the Veterans Affairs Diabetes Trial (VADT)
Robert J. Anderson; Gideon D. Bahn; Nicholas V. Emanuele; Jennifer B. Marks; William C. Duckworth; for the VADT Study Group
Topics:
kidney
,
veterans affairs diabetes trial
,
american college of radiology
,
american college of rheumatology
,
glycemic control
Diabetes Care September 2014, Vol.37, 2782-2788. doi:https://doi.org/10.2337/dc14-0284
Cardiovascular and Metabolic Risk
Effect of 8 Weeks of Overfeeding on Ectopic Fat Deposition and Insulin Sensitivity: Testing the “Adipose Tissue Expandability” Hypothesis
Darcy L. Johannsen; Yourka Tchoukalova; Charmaine S. Tam; Jeffrey D. Covington; Wenting Xie; Jean-Marc Schwarz; Sudip Bajpeyi; Eric Ravussin
Topics:
adipocytes
,
overnutrition
,
insulin sensitivity
,
weight gain
,
adipose tissue
Diabetes Care September 2014, Vol.37, 2789-2797. doi:https://doi.org/10.2337/dc14-0761
Contributors to Mortality in High-Risk Diabetic Patients in the Diabetes Heart Study
Amanda J. Cox; Fang-Chi Hsu; Barry I. Freedman; David M. Herrington; Michael H. Criqui; J. Jeffrey Carr; Donald W. Bowden
Topics:
cardiovascular diseases
,
carotid intima-media thickness
,
cholesterol
,
c-reactive protein
,
diabetes mellitus, type 2
Diabetes Care September 2014, Vol.37, 2798-2803. doi:https://doi.org/10.2337/dc14-0081
Lipid Profiling Reveals Different Therapeutic Effects of Metformin and Glipizide in Patients With Type 2 Diabetes and Coronary Artery Disease
Yifei Zhang; Chunxiu Hu; Jie Hong; Jun Zeng; Shenghan Lai; Ankang Lv; Qing Su; Yan Dong; Zhiguang Zhou; Weili Tang; Jiajun Zhao; Lianqun Cui; Dajin Zou; Dawang Wang; Hong Li; Chao Liu; Guoting Wu; Jie Shen; Dalong Zhu; Weiqing Wang; Weifeng Shen; Guang Ning; Guowang Xu
Topics:
glipizide
,
lipids
,
metformin
,
serum specimen
,
diabetes mellitus, type 2
Diabetes Care September 2014, Vol.37, 2804-2812. doi:https://doi.org/10.2337/dc14-0090
Increased Cardiometabolic Risk Factors and Inflammation in Adipose Tissue in Obese Subjects Classified as Metabolically Healthy
Javier Gómez-Ambrosi; Victoria Catalán; Amaia Rodríguez; Patricia Andrada; Beatriz Ramírez; Patricia Ibáñez; Neus Vila; Sonia Romero; María A. Margall; María J. Gil; Rafael Moncada; Víctor Valentí; Camilo Silva; Javier Salvador; Gema Frühbeck
Topics:
adipose tissue
,
inflammation
,
monoamine oxidase
,
obesity
,
cardiometabolic risk factors
Diabetes Care September 2014, Vol.37, 2813-2821. doi:https://doi.org/10.2337/dc14-0937
The Look AHEAD Trial: Bone Loss at 4-Year Follow-up in Type 2 Diabetes
Edward W. Lipkin; Ann V. Schwartz; Andrea M. Anderson; Cralen Davis; Karen C. Johnson; Edward W. Gregg; George A. Bray; Robert Berkowitz; Anne L. Peters; Amelia Hodges; Cora Lewis; Steven E. Kahn; the Look AHEAD Research Group
Topics:
diabetes mellitus, type 2
,
follow-up
,
hip joint
,
hip region
,
osteopenia
Diabetes Care September 2014, Vol.37, 2822-2829. doi:https://doi.org/10.2337/dc14-0762
Novel Communications in Diabetes
Glycation of Fetal Hemoglobin Reflects Hyperglycemia Exposure In Utero
Felix O. Dupont; Marie-France Hivert; Catherine Allard; Julie Ménard; Patrice Perron; Luigi Bouchard; Julie Robitaille; Jean-Charles Pasquier; Christiane Auray-Blais; Jean-Luc Ardilouze
Topics:
biological markers
,
fetal hemoglobin
,
fetus
,
glucose
,
glycation
Diabetes Care September 2014, Vol.37, 2830-2833. doi:https://doi.org/10.2337/dc14-0549
Position Statement
Care of Young Children With Diabetes in the Child Care Setting: A Position Statement of the American Diabetes Association
Linda M. Siminerio; Anastasia Albanese-O’Neill; Jane L. Chiang; Katie Hathaway; Crystal C. Jackson; Jill Weissberg-Benchell; Janel L. Wright; Alan L. Yatvin; Larry C. Deeb
Topics:
blood glucose
,
child
,
hyperglycemia
,
hypoglycemia
,
glucagon
Diabetes Care September 2014, Vol.37, 2834-2842. doi:https://doi.org/10.2337/dc14-1676
Scientific Statement
Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
Sarah D. de Ferranti, MD, MPH; Ian H. de Boer, MD, MS; Vivian Fonseca, MD; Caroline S. Fox, MD, MPH; Sherita Hill Golden, MD, MHS; Carl J. Lavie, MD; Sheela N. Magge, MD, MSCE; Nikolaus Marx, MD; Darren K. McGuire, MD; Trevor J. Orchard, MD, MMedSci; Bernard Zinman, MD; Robert H. Eckel, MD, FAHA
Diabetes Care September 2014, Vol.37, 2843-2863. doi:https://doi.org/10.2337/dc14-1720
Consensus Report
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle; George L. Bakris; Rudolf W. Bilous; Jane L. Chiang; Ian H. de Boer; Jordi Goldstein-Fuchs; Irl B. Hirsch; Kamyar Kalantar-Zadeh; Andrew S. Narva; Sankar D. Navaneethan; Joshua J. Neumiller; Uptal D. Patel; Robert E. Ratner; Adam T. Whaley-Connell; Mark E. Molitch
Topics:
albuminuria
,
cardiovascular diseases
,
clinical research
,
hypertension
,
kidney failure, chronic
Diabetes Care September 2014, Vol.37, 2864-2883. doi:https://doi.org/10.2337/dc14-1296
Review
The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
Topics:
diabetes mellitus complications
,
diabetes mellitus, type 2
,
dipeptidyl-peptidase iv
,
endothelium
,
glycemic control
Diabetes Care September 2014, Vol.37, 2884-2894. doi:https://doi.org/10.2337/dc14-0865
Erratum
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37:2159–2167
Carol Wysham; Thomas Blevins; Richard Arakaki; Gildred Colon; Pedro Garcia; Charles Atisso; Debra Kuhstoss; Mark Lakshmanan
Topics:
awards and prizes
,
diabetes mellitus, type 2
,
dulaglutide
,
exenatide
,
metformin/pioglitazone
Diabetes Care September 2014, Vol.37, 2895. doi:https://doi.org/10.2337/dc14-er10
Issues and Events
Issues and Events
Topics:
podcasts
Diabetes Care September 2014, Vol.37, 2896. doi:https://doi.org/10.2337/dc14-ie10
E-Letters: Observations
Dry Eye Syndrome in Subjects With Diabetes and Association With Neuropathy
Vasilis Achtsidis; Ioanna Eleftheriadou; Eleftheria Kozanidou; Konstantine I. Voumvourakis; Eleftherios Stamboulis; Panos G. Theodosiadis; Nicholas Tentolouris
Topics:
dry eye syndromes
,
neuropathy
,
cornea
Diabetes Care September 2014, Vol.37, e210-e211. doi:https://doi.org/10.2337/dc14-0860
Glycemic Control in Diabetic Patients With Impaired Endogenous Insulin Secretory Capacity Is Vulnerable After a Natural Disaster: Study of Great East Japan Earthquake
Mamiko Tanaka; Junta Imai; Michihiro Satoh; Takanao Hashimoto; Tomohito Izumi; Shojiro Sawada; Kenji Uno; Yutaka Hasegawa; Keizo Kaneko; Tetsuya Yamada; Yasushi Ishigaki; Yutaka Imai; Hideki Katagiri
Topics:
earthquakes
,
glycemic control
,
insulin
,
natural disasters
,
c-peptide
Diabetes Care September 2014, Vol.37, e212-e213. doi:https://doi.org/10.2337/dc14-1479
Latent Autoimmune Diabetes in Stiff-Person Syndrome
Topics:
autoimmunity
,
insulin
,
stiff-person syndrome
Diabetes Care September 2014, Vol.37, e214-e215. doi:https://doi.org/10.2337/dc14-1444
E-Letters: Comments and Responses
Comment on Bordeleau et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366
Topics:
basal insulin
,
cancer
,
insulin glargine
,
omega-3 fatty acids
Diabetes Care September 2014, Vol.37, e216. doi:https://doi.org/10.2337/dc14-1075
Response to Suissa and Azoulay. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366
Topics:
basal insulin
,
cancer
,
insulin glargine
,
omega-3 fatty acids
Diabetes Care September 2014, Vol.37, e217. doi:https://doi.org/10.2337/dc14-1220
Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670
Topics:
diabetes mellitus, type 1
,
exenatide
,
insulin sensitivity
Diabetes Care September 2014, Vol.37, e218. doi:https://doi.org/10.2337/dc14-1052
Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670
Topics:
diabetes mellitus, type 1
,
exenatide
,
insulin sensitivity
Diabetes Care September 2014, Vol.37, e219-e220. doi:https://doi.org/10.2337/dc14-1482
Comment on Bordeleau et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366
Marjolein M.J. Zanders; Andrew G. Renehan; Samantha L. Bowker; Bendix Carstensen; Lonneke V. van de Poll-Franse; Jeffrey A. Johnson
Topics:
basal insulin
,
cancer
,
insulin glargine
,
omega-3 fatty acids
Diabetes Care September 2014, Vol.37, e221-e222. doi:https://doi.org/10.2337/dc14-1380
Response to Zanders et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366
Topics:
basal insulin
,
cancer
,
insulin glargine
,
omega-3 fatty acids
,
origin trial
Diabetes Care September 2014, Vol.37, e223. doi:https://doi.org/10.2337/dc14-1567
Comment on Kramer et al. Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia. Diabetes Care 2014;37:1076–1082
Topics:
blood glucose normal
,
diabetes mellitus, type 1
,
glucagon
,
glucose
Diabetes Care September 2014, Vol.37, e224. doi:https://doi.org/10.2337/dc14-1500
Response to Comment on Kramer et al. Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia. Diabetes Care 2014;37:1076–1082
Topics:
blood glucose normal
,
diabetes mellitus, type 1
,
glucagon
,
glucose
Diabetes Care September 2014, Vol.37, e225. doi:https://doi.org/10.2337/dc14-1636
Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197
Nick S. Oliver; Mark L. Evans; Roman Hovorka; Simon Heller; Desmond G. Johnston; Stephanie A. Amiel; Katharine Barnard
Topics:
artificial pancreas
,
engineering
Diabetes Care September 2014, Vol.37, e226-e227. doi:https://doi.org/10.2337/dc14-1499
Response to Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197
Topics:
artificial pancreas
,
engineering
Diabetes Care September 2014, Vol.37, e228. doi:https://doi.org/10.2337/dc14-1693
Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774
Topics:
insulin analogs
,
insulin
Diabetes Care September 2014, Vol.37, e229-e230. doi:https://doi.org/10.2337/dc14-1390
Response to Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774
Topics:
insulin analogs
Diabetes Care September 2014, Vol.37, e231. doi:https://doi.org/10.2337/dc14-1605
Response to Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774
Topics:
insulin analogs
Diabetes Care September 2014, Vol.37, e232. doi:https://doi.org/10.2337/dc14-1643